BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn® December 27, 2022 Read More »
How Stem Cells Contribute to Aging and Age-Related Diseases with Rob Signer December 26, 2022 Read More »
Updated Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy December 20, 2022 Read More »
Angiocrine Bioscience Announces it has been awarded a $15M Grant from the California Institute for Regenerative Medicine for AB-205 Phase 3 Clinical Trial December 19, 2022 Read More »
Cell and Gene Therapy Companies Leverage GenScript’s cGMP sgRNA Capability to Accelerate Speed to Market December 15, 2022 Read More »
Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell Therapies at 2022 ASH Annual Meeting December 13, 2022 Read More »
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 December 12, 2022 Read More »
